Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CENTAUR: Non-statin Treatments on Apo A-I
NCT00728910Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Jun 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fenofibric acid in atherogenic dyslipidemia (AD), sponsored by University of Pennsylvania. Primary endpoints: Apolipoprotein A-I Fractional Catabolic Rate at 22 weeks, Apolipoprotein A-I Production Rate at 22 weeks and 1 more. Started Jun 2008; status: completed.
02
Drugs
fenofibric acid
03
Conditions
atherogenic dyslipidemia (AD)
Beyond the preview
Go deeper on NCT00728910.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728910.